Stock Events

Mckesson 

M$9,489.53
414
+M$0+0% Wednesday 15:08

Statistics

Day High
9,489.53
Day Low
9,489.53
52W High
11,470
52W Low
7,688.45
Volume
2,900
Avg. Volume
13
Mkt Cap
1.05T
P/E Ratio
27.65
Dividend Yield
0.59%
Dividend
55.98

Upcoming

Dividends

0.59%Dividend Yield
10Y Growth
14.56%
5Y Growth
9.52%
3Y Growth
10.66%
1Y Growth
21.53%

Earnings

29OctExpected
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
Next
5.87
6.54
7.21
7.88
Expected EPS
7.391025
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow MCK.MX. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
AMERISOURCEBERGEN CORP
ABC
Mkt Cap34.08B
AmerisourceBergen is a direct competitor, operating in the same pharmaceutical distribution and healthcare services sector as McKesson.
Cardinal Health
CAH
Mkt Cap27.49B
Cardinal Health is another major player in the pharmaceutical distribution industry, directly competing with McKesson in terms of product range and services.
Walgreens Boots Alliance
WBA
Mkt Cap7.99B
Walgreens Boots Alliance, through its wholesale division, competes in the pharmaceutical wholesaling and distribution market.
CVS Health
CVS
Mkt Cap72.01B
CVS Health operates in the healthcare and pharmaceuticals sector, competing with McKesson in pharmacy services and healthcare solutions.
Owens & Minor
OMI
Mkt Cap1.2B
Owens & Minor provides healthcare logistics services, competing with McKesson in the medical supplies distribution sector.
Henry Schein
HSIC
Mkt Cap8.94B
Henry Schein competes in the distribution of healthcare products and services, overlapping with McKesson's medical-surgical segment.
Patterson Companies
PDCO
Mkt Cap1.98B
Patterson Companies competes with McKesson in the distribution of dental and animal health products, areas where McKesson also operates.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap21.38B
Teva Pharmaceutical Industries, as a large generic pharmaceutical manufacturer, competes indirectly by supplying similar generic drugs as McKesson.
Johnson & Johnson
JNJ
Mkt Cap399.26B
Johnson & Johnson, through its broad range of healthcare products, competes in various segments where McKesson is also present.

About

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys; connects pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions; and provides third-party logistics and wholesale distribution support solutions. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
Show more...
CEO
Mr. Brian S. Tyler Ph.D.
Employees
58000
Country
United States
ISIN
US58155Q1031

Listings